Crowley Wealth Management »

Neurocrine Biosciences shares owned by Crowley Wealth Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Crowley Wealth Management from 13F filings

Historical chart of Crowley Wealth Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Crowley Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Crowley Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $140k 1.0k 140.38
2025-06-30 $126k 1.0k 125.69
2025-03-31 $111k 1.0k 110.60
2024-12-31 $137k 1.0k 136.50

More positions owned by Crowley Wealth Management

Apple Common Stock (AAPL)
Tesla Common Stock (TSLA)
Proshares Ultra Qqq Etf Uit Exchange Traded (QLD)
Abbvie Common Stock (ABBV)
Lowes Cos Common Stock (LOW)
Proshares Ultra S&p 500 Etf Uit Exchange Traded (SSO)
Microsoft Corp Common Stock (MSFT)
Jpmorgan Chase & Co Common Stock (JPM)
Home Depot Common Stock (HD)
Proshares Ultra Russell 2000 Etf Uit Exchange Traded (UWM)
Disney Walt Common Stock (DIS)
Amgen Common Stock (AMGN)
Stryker Corp Common Stock (SYK)
Amazon.com Common Stock (AMZN)
Abbott Labs Common Stock (ABT)

View all positions for Crowley Wealth Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
Jpmorgan Chase & Co
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Morgan Stanley
Wellington Management Company
Bellevue Group
Thomas Stevens, CFA"
Deerfield Management Company
Rtw Investments
Millennium Management

View all funds holding Neurocrine Biosciences